Christensen LL - Search Results

1

Muscle function following testosterone replacement in men on opioid therapy for chronic non-cancer pain: A randomized controlled trial.

Kolind MI, Christensen LL, Caserotti P, Andersen MS, Glintborg D. Kolind MI, et al. Among authors: christensen ll. Andrology. 2022 Mar;10(3):551-559. doi: 10.1111/andr.13147. Epub 2021 Dec 30. Andrology. 2022. PMID: 34933416 Free article. Clinical Trial.

2

Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels.

Kvorning T, Christensen LL, Madsen K, Nielsen JL, Gejl KD, Brixen K, Andersen M. Kvorning T, et al. Among authors: christensen ll. J Am Geriatr Soc. 2013 Jun;61(6):957-962. doi: 10.1111/jgs.12279. Epub 2013 Jun 3. J Am Geriatr Soc. 2013. PMID: 23730808 Clinical Trial.

3

Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.

Glintborg D, Christensen LL, Kvorning T, Larsen R, Brixen K, Hougaard DM, Richelsen B, Bruun JM, Andersen M. Glintborg D, et al. Among authors: christensen ll. Mediators Inflamm. 2013;2013:539156. doi: 10.1155/2013/539156. Epub 2013 Sep 8. Mediators Inflamm. 2013. PMID: 24089589 Free PMC article. Clinical Trial.

4

Effect of testosterone on markers of mitochondrial oxidative phosphorylation and lipid metabolism in muscle of aging men with subnormal bioavailable testosterone.

Petersson SJ, Christensen LL, Kristensen JM, Kruse R, Andersen M, Højlund K. Petersson SJ, et al. Among authors: christensen ll. Eur J Endocrinol. 2014 Jul;171(1):77-88. doi: 10.1530/EJE-14-0006. Epub 2014 Apr 23. Eur J Endocrinol. 2014. PMID: 24760536 Clinical Trial.

5

Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: Possible relation to changes in body composition.

Glintborg D, Christensen LL, Kvorning T, Larsen R, Højlund K, Brixen K, Hougaard DM, Handberg A, Andersen M. Glintborg D, et al. Among authors: christensen ll. Scand J Clin Lab Invest. 2015;75(8):659-66. Epub 2015 Aug 12. Scand J Clin Lab Invest. 2015. PMID: 26264425 Clinical Trial.

6

Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.

Pedersen L, Christensen LL, Pedersen SM, Andersen M. Pedersen L, et al. Among authors: christensen ll. J Endocrinol Invest. 2017 May;40(5):529-538. doi: 10.1007/s40618-016-0597-3. Epub 2016 Dec 20. J Endocrinol Invest. 2017. PMID: 28000180 Clinical Trial.

7

Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial.

Jensen RC, Christensen LL, Nielsen J, Schrøder HD, Kvorning T, Gejl K, Højlund K, Glintborg D, Andersen M. Jensen RC, et al. Among authors: christensen ll. Andrology. 2018 Jul;6(4):547-555. doi: 10.1111/andr.12492. Epub 2018 Apr 15. Andrology. 2018. PMID: 29656500 Free article. Clinical Trial.

8

The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake.

Jensen CH, Kosmina R, Rydén M, Baun C, Hvidsten S, Andersen MS, Christensen LL, Gastaldelli A, Marraccini P, Arner P, Jørgensen CD, Laborda J, Holst JJ, Andersen DC. Jensen CH, et al. Among authors: christensen ll. EBioMedicine. 2019 Aug;46:368-380. doi: 10.1016/j.ebiom.2019.07.070. Epub 2019 Aug 3. EBioMedicine. 2019. PMID: 31383551 Free PMC article.

9

Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.

Glintborg D, Vaegter HB, Christensen LL, Bendix E, Graven-Nielsen T, Andersen PG, Andersen M. Glintborg D, et al. Among authors: christensen ll. Eur J Endocrinol. 2020 Jun;182(6):539-548. doi: 10.1530/EJE-19-0979. Eur J Endocrinol. 2020. PMID: 32213659 Clinical Trial.

10

Effect of long-term testosterone therapy on molecular regulators of skeletal muscle mass and fibre-type distribution in aging men with subnormal testosterone.

Kruse R, Petersson SJ, Christensen LL, Kristensen JM, Sabaratnam R, Ørtenblad N, Andersen M, Højlund K. Kruse R, et al. Among authors: christensen ll. Metabolism. 2020 Nov;112:154347. doi: 10.1016/j.metabol.2020.154347. Epub 2020 Aug 25. Metabolism. 2020. PMID: 32853647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page